(Q53667768)

17 May 2018

title

A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. (English)

1 reference

17 May 2018

author

Mario Cozzolino

1

1 reference

17 May 2018

author name string

Yan Lu

2

1 reference

17 May 2018

Tetsuhiko Sato

3

1 reference

17 May 2018

Jing Yang

4

1 reference

17 May 2018

Ignacio Gonzalez Suarez

5

1 reference

17 May 2018

Diego Brancaccio

6

1 reference

17 May 2018

Eduardo Slatopolsky

7

1 reference

17 May 2018

Adriana S Dusso

8

1 reference

17 May 2018

publication date

5 July 2005

1 reference

17 May 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

17 May 2018

volume

289

1 reference

17 May 2018

issue

5

1 reference

17 May 2018

page(s)

F1096-102

1 reference

17 May 2018

The EGF/TGFalpha response element within the TGFalpha promoter consists of a multi-complex regulatory element

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

Tyrosine kinase inhibitors: rationale, mechanisms of action, and implications for drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

Epidermal growth factor regulates the expression of its own receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

Renal osteodystrophy: pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

Nuclear localization of EGF receptor and its potential new role as a transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

The hyperparathyroidism of chronic renal failure: a disorder of growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

ZD1839 (IRESSA): a selective EGFR-TK inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

Epidermal growth factor receptor status in hyperparathyroidism: immunocytochemical and In situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00167.2005

10.1152/AJPRENAL.00167.2005

21 January 2018

Identifiers

DOI

1 reference

17 May 2018

PubMed ID

15998841

1 reference

17 May 2018